1-3 of 3
Joaquin Panadero
Close
Sort by
Journal Articles

TFDP3 and DDX53 are Highly Re-Expressed after One Cycle of Azacitidine in Myelodysplastic Syndrome Patients Achieving Complete Response: A Cancer Testis Antigen RNA-Seq Screening

Ana M Hurtado López, Tzu Hua Chen-Liang, Joaquín Panadero, Eduardo José Salido, MD, Victor Beltrán, Begoña Muiña, Noelia Navarro-Villamor, Inés Calabria, Ana Isabel Antón, Francisco José Ortuño, Vicente Vicente, MD PhD, Andres Jerez
Journal: Blood
Blood (2018) 132 (Supplement 1): 4340.
https://doi.org/10.1182/blood-2018-99-117851
Published: 2018
Journal Articles

Global and Targeted RNA-Sequencing Assessment of Cancer Testis Antigen Re-Expression Following Azacitidine in Myelodysplastic Syndromes

Ana M Hurtado, Tzu Hua Chen-Liang, Joaquín Panadero, Eduardo José Salido, MD, Victor Beltrán, Begoña Muiña, Noelia Navarro-Villamor, Inés Calabria, Ana Isabel Antón, Andres Jerez
Journal: Blood
Blood (2017) 130 (Supplement 1): 1695.
https://doi.org/10.1182/blood.V130.Suppl_1.1695.1695
Published: 2017
Journal Articles

Unraveling a novel transcription factor code determining the human arterial-specific endothelial cell signature

Xabier L. Aranguren, Xabier Agirre, Manu Beerens, Giulia Coppiello, Maialen Uriz, Ine Vandersmissen, Mohammed Benkheil, Joaquin Panadero, Natalia Aguado, Alberto Pascual-Montano, Victor Segura, Felipe Prósper, Aernout Luttun
Journal: Blood
Blood (2013) 122 (24): 3982–3992.
https://doi.org/10.1182/blood-2013-02-483255
Published: 2013
Includes: Supplemental data